Fair Pricing – Striking The Balance 10/05/2019 Editorial team Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations, shared his view on fair pricing with Health Policy Watch: “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is […] Continue reading -> WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> WHO Adapts Ebola Vaccination Strategy in the DRC to Account for Insecurity and Community Feedback 08/05/2019 Editorial team [WHO News Release] WHO’s Strategic Advisory Group of Experts (SAGE) today issued new recommendations to address vaccination challenges in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC). Image Credits: WHO/J. D. Kannah. Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO is establishing technical advisory group and roster of experts on digital health 10/05/2019 Editorial team [WHO News Release] WHO is establishing a global multi-disciplinary technical group to advise us on issues related to digital health. Continue reading -> WHO Adapts Ebola Vaccination Strategy in the DRC to Account for Insecurity and Community Feedback 08/05/2019 Editorial team [WHO News Release] WHO’s Strategic Advisory Group of Experts (SAGE) today issued new recommendations to address vaccination challenges in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC). Image Credits: WHO/J. D. Kannah. Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Adapts Ebola Vaccination Strategy in the DRC to Account for Insecurity and Community Feedback 08/05/2019 Editorial team [WHO News Release] WHO’s Strategic Advisory Group of Experts (SAGE) today issued new recommendations to address vaccination challenges in the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC). Image Credits: WHO/J. D. Kannah. Continue reading -> Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ghana launches the world’s largest vaccine drone delivery network 24/04/2019 Editorial team [Gavi, The Vaccine Alliance, Press Release] With support from Gavi, The UPS Foundation and other partners, Zipline drones will serve up to 2,000 health facilities and 12 million people in Ghana. Omenako, Ghana, 24 April 2019 – Gavi, the Vaccine Alliance today announced support for the expansion of a medical drone network into Ghana. Zipline, a […] Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> Posts navigation Older postsNewer posts